Via Kaplan-Meier analysis, we showed that increased expression of YEATS2 (Figure 8I) or ZZZ3 (Figure 8J) predicted a poorer prognosis across different histological types of sarcoma, suggesting the ATAC complex may be a key oncogenic driver in multiple sarcomas in addition to EHE. Here, YEATS2 is linked to sarcoma.